Chaperone proteins identified from synthetic proteasome inhibitor-induced inclusions in PC12 cells by proteomic analysis

Acta Biochimica et Biophysica Sinica

Volumn 40, Issue 5, 2008, Pages 406-418

  Li, Xing'An ^a,b   Zhang, Yingjiu ^b   Hu, Yihong ^a   Chang, Ming ^a   Liu, Tao ^a   Wang, Danping ^a   Zhang, Yu ^a   Zhang, Lei ^a   Hu, Linsen ^a  

^a JILIN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Chaperone proteins; Proteomic analysis; PSI induced inclusions

Indexed keywords

CHAPERONE; PROTEASOME; PROTEOME;

ANIMAL; ARTICLE; CELL INCLUSION; CELL STRAIN; DRUG ANTAGONISM; METABOLISM; RAT;

ANIMALS; INCLUSION BODIES; MOLECULAR CHAPERONES; PC12 CELLS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOME; RATS;

EID: 43949146653     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2008.00416.x     Document Type: Article

References (65)

1. Duyckaerts C, Hauw JJ, Am J. Lewy bodies, a misleading marker for Parkinson's disease? Bull Acad Natl Med 2003, 187 : 277 292.
2. Sone M, Yoshida M, Hashizume Y, Hishikawa N, Sobue G. α-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy. Acta Neuropathol (Berl) 2005, 110 : 19 26.
3. Kahle PJ, Neumann M, Ozmen L, Müller V, Odoy S, Okamoto N, Jacobsen H et al. Selective insolubility of α-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model. Am J Pathol 2001, 159 : 2215 2225.
4. McNaught KS, Olanow CW. Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease. Neurobiol Aging 2006, 27 : 530 545.
5. Leverenz JB, Umar I, Wang Q, Montine TJ, McMillan PJ, Tsuang DW, Jin J et al. Proteomic identification of novel proteins in cortical Lewy bodies. Brain Pathol 2007, 17 : 139 145.
6. Lee HJ, Lee SJ. Characterization of cytoplasmic α-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells. J Biol Chem 2002, 277 : 48976 48983.
7. Galvin JE, Giasson B, Hurtig HI, Lee VM, Trojanowski JQ. Neurodegeneration with brain iron accumulation, type 1 is characterized by α-, β-, and γ-synuclein neuropathology. Am J Pathol 2000, 157 : 361 368.
8. Nishiyama K, Murayama S, Shimizu J, Ohya Y, Kwak S, Asayama K, Kanazawa I. Cu/Zn superoxide dismutase-like immunoreactivity is present in Lewy bodies from Parkinson disease: a light and electron microscopic immunocytochemical study. Acta Neuropathol 1995, 89 : 471 474.
9. Shults CW. Lewy bodies. Proc Natl Acad Sci USA 2006, 103 : 1661 1668.
10. Jin J, Meredith GE, Chen L, Zhou Y, Xu J, Shie FS, Lockhart P et al. Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. Brain Res Mol Brain Res 2005, 134 : 119 138.
11. McNaught KS, Olanow CW. Proteasome inhibitor-induced model of Parkinson's disease. Ann Neurol 2006, 60 : 243 247.
12. Trimmer PA, Borland MK, Keeney PM, Bennett JP Jr., Parker WD Jr. Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies. J Neurochem 2004, 88 : 800 812.
13. McNaught KS, Mytilineou C, Jnobaptiste R, Yabut J, Shashidharan P, Jennert P, Olanow CW. Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. J Neurochem 2002, 81 : 301 306.
14. Petrucelli L, O'Farrell C, Lockhart PJ, Baptista M, Kehoe K, Vink L, Choi P et al. Parkin protects against the toxicity associated with mutant α-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron 2002, 36 : 1007 1019.
15. Rideout HJ, Larsen KE, Sulzer D, Stefanis L. Proteasomal inhibition leads to formation of ubiquitin/α-synuclein-immunoreactive inclusions in PC12 cells. J Neurochem 2001, 78 : 899 908.
16. Olanow CW, Perl DP, DeMartino GN, McNaught KS. Lewy-body formation is an aggresome-related process: a hypothesis. Lancet Neurol 2004, 3 : 496 503.
17. Kopito RR. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 2000, 10 : 524 530.
18. Zhou Y, Gu G, Goodlett DR, Zhang T, Pan C, Montine TJ, Montine KS et al. Analysis of α-synuclein-associated proteins by quantitative proteomics J Biol Chem 2004 279 : 39155 39164.
19. Tsai YC, Fishman PS, Thakor NV, Oyler GA. Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J Biol Chem 2003, 278 : 22044 22055.
20. Chillarón J, Haas IG. Dissociation from BiP and retrotranslocation of unassembled immunoglobulin light chains are tightly coupled to proteasome activity. Mol Biol Cell 2000, 11 : 217 226.
21. Werner ED, Brodsky JL, McCracken AA. Proteasome-dependent endoplasmic reticulum-associated protein degradation: an unconventional route to a familiar fate. Proc Natl Acad Sci USA 1996, 93 : 13797 13801.
22. Nawrocki ST, Carew JS, Dunner K, Boise LH, Chiao PJ, Huang P, Abbruzzese JL et al. Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells. Cancer Res 2005, 65 : 11510 11519.
23. Garcia-Mata R, Gao YS, Sztul E. Hassles with taking out the garbage: aggravating aggresomes. Traffic 2002, 3 : 388 396.
24. Ito H, Kamei K, Iwamoto I, Inaguma Y, Nohara D, Kato K. Phosphorylation-induced change of the oligomerization state of a B-crystallin. J Biol Chem 2001, 276 : 5346 5352.
25. Kaneko K, Hachiya NS. The alternative role of 14-3-3 zeta as a sweeper of misfolded proteins in disease conditions. Med Hypotheses 2006, 67 : 169 171.
26. Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 1998, 8 : 397 403.
27. Wigley WC, Fabunmi RP, Lee MG, Marino CR, Muallem S, DeMartino GN, Thomas PJ. Dynamic association of proteasomal machinery with the centrosome. J Cell Biol 1999, 145 : 481 490.
28. Fabunmi RP, Wigley WC, Thomas PJ, DeMartino GN. Activity and regulation of the centrosome-associated proteasome. J Biol Chem 2000, 275 : 409 413.
29. Gai WP, Yuan HX, Li XQ, Power JT, Blumbergs PC, Jensen PH. In situ and in vitro study of colocalization and segregation of α-synuclein, ubiquitin, and lipids in Lewy bodies. Exp Neurol 2000, 166 : 324 333.
30. Atadzhanov M, Zumla A, Mwaba P. Study of familial Parkinson's disease in Russia, Uzbekistan and Zambia. Postgrad Med J 2005, 81 : 117 121.
31. Pinelli M, Giacchetti M, Acquaviva F, Cocozza S, Donnarumma G, Lapice E, Riccardi G et al. β2-Adrenergic receptor and UCP3 variants modulate the relationship between age and type 2 diabetes mellitus. BMC Med Genet 2006, 7 : 85.
32. Jacobs DI, van Rijssen MS, van der Heijden R, Verpoorte R. Sequential solubilization of proteins precipitated with trichloro-acetic acid in acetone from cultured Catharanthus roseus cells yields 52% more spots after two-dimensional electrophoresis. Proteomics 2001, 1 : 1345 1350.
33. Basso M, Giraudo S, Lopiano L, Bergamasco B, Bosticco E, Cinquepalmi A, Fasano M. Proteome analysis of mesencephalic tissues: evidence for Parkinson's disease. Neurol Sci 2003, 24 : 155 156.
34. Yin Z, Stead D, Selway L, Walker J, Riba-Garcia I, McLnerney T, Gaskell S et al. Proteomic response to amino acid starvation in Candida albicans and Saccharomyces cerevisiae. Proteomics 2004, 4 : 2425 2436.
35. Stead D, Findon H, Yin Z, Walker J, Selway L, Cash P, Dujon BA et al. Proteomic changes associated with inactivation of the Candida glabrata ACE2 virulence-moderating gene. Proteomics 2005, 5 : 1838 1848.
36. Katsuse O, Iseki E, Marui W, Kosaka K. Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies. J Neurol Sci 2003, 211 : 29 35.
37. Sian J, Hensiek R, Senitz D, Muench G, Jellinger K, Riederer P, Gerlach M. A novel technique for the isolation of Lewy bodies in brain. Acta Neuropathol (Berl) 1998, 96 : 111 115.
38. Pasquali C, Fialka I, Huber LA. Subcellular fractionation, electromigration analysis and mapping of organelles. J Chromatogr B Biomed Sci Appl 1999, 722 : 89 102.
39. Taylor SW, Fahy E, Ghosh SS. Global organellar proteomics. Trends Biotechnol 2003, 1 : 82 88.
40. Basso M, Giraudo S, Corpillo D, Bergamasco B, Lopiano L, Fasano M. Proteome analysis of human substantia nigra in Parkinson's disease. Proteomics 2004, 4 : 3943 3952.
41. Alim MA, Hossain MS, Arima K, Takeda K, Izumiyama Y, Nakamura M, Kaji H et al. Tubulin seeds α-synuclein fibril formation. J Biol Chem 2002, 277 : 2112 2117.
42. Schipper HM, Liberman A, Stopa EG. Neural heme oxygenase-1 expression in idiopathic Parkinson's disease. Exp Neurol 1998, 150 : 60 68.
43. Ostrerova N, Petrucelli L, Farrer M, Mehta N, Choi P, Hardy J, Wolozin B. α-Synuclein shares physical and functional homology with 14-3-3 proteins. J Neurosci 1999, 19 : 5782 5791.
44. Ii K, Ito H, Tanaka K, Hirano A. Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly. J Neuropathol Exp Neurol 1997, 56 : 125 131.
45. McNaught KS, Shashidharan P, Perl DP, Jenner P, Olanow CW. Aggresome-related biogenesis of Lewy bodies. Eur J Neurosci 2002, 16 : 2136 2148.
46. Hirabayashi M, Inoue K, Tanaka K, Nakadate K, Ohsawa Y, Kamei Y, Popiel AH et al. VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ 2001, 8 : 977 984.
47. Schipper HM, Liberman A, Stopa EG. Neural heme oxygenase-1 expression in idiopathic Parkinson's disease. Exp Neurol 1998, 150 : 60 68.
48. Castellani R, Smith MA, Richey PL, Perry G. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res 1996, 737 : 195 200.
49. Yoo MS, Chun HS, Son JJ, DeGiorgio LA, Kim DJ, Peng C, Son JH. Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease. Brain Res Mol Brain Res 2003, 110 : 76 84.
50. Sherman MY, Goldberg AL. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 2001, 29 : 15 32.
51. Luo GR, Chen S, Le WD. Are heat shock proteins therapeutic target for Parkinson's disease? Int J Biol Sci 2006, 3 : 20 26.
52. Liu H, Bowes RC 3rd., van de Water B, Sillence C, Nagelkerke JF, Stevens JL. Endoplasmic reticulum chaperones GRP78 and calreticulin prevent oxidative stress, Ca2+ disturbances, and cell death in renal epithelial cells. J Biol Chem 1997, 272 : 21751 21759.
53. Rao RV, Castro-Obregon S, Frankowski H, Schuler M, Stoka V, del Rio G, Bredesen DE et al. Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J Biol Chem 2002, 277 : 21836 21842.
54. Chichiarelli S, Ferraro A, Altieri F, Eufemi M, Coppari S, Grillo C, Arcangeli V et al. The stress protein ERp57/GRP58 binds specific DNA sequences in HeLa cells. J Cell Physiol 2007, 210 : 343 351.
55. Hetz C, Russelakis-Carneiro M, Walchli S, Carboni S, Vial-Knecht E, Maundrell K, Castilla J et al. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J Neurosci 2005, 25 : 2793 2802.
56. Wadhwa R, Taira K, Kaul SC. An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where? Cell Stress Chaperones 2002, 7 : 309 316.
57. Jinghua J, Hulette C, Wang Y, Zhang T, Pan C, Wadhwa R, Zhang J. Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease. Mol Cell Proteomics 2006, 5 : 1193 1204.
58. Yoo BC, Kim SH, Cairns N, Fountoulakis M, Lubec G. Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease. Biochem Biophys Res Commun 2001, 280 : 249 258.
59. Fullekrug J, Sonnichsen B, Wunsch U, Arseven K, Nguyen Van P, Soling HD, Mieskes G. CaBP1, a calcium binding protein of the thioredoxin family, is a resident KDEL protein of the ER and not of the intermediate compartment. J Cell Sci 1994, 107 : 2719 2727.
60. Meunier L, Usherwood YK, Chung KT, Hendershot LM. A subset of chaperones and folding enzymes form multiprotein complexes in endoplasmic reticulum to bind nascent proteins. Mol Biol Cell 2002, 13 : 4456 4469.
61. Schweizer A, Peter F, Van PN, Soling HD, Hauri HP. A luminal calcium-binding protein with a KDEL endoplasmic reticulum retention motif in the ER-Golgi intermediate compartment. Eur J Cell Biol 1993, 60 : 366 370.
62. Megidish T, Takio K, Titani K, Iwabuchi K, Hamaguchi A, Igarashi Y, Hakomori S. Endogenous substrates of sphingosine-dependent kinases (SDKs) are chaperone proteins: heat shock proteins, glucose-regulated proteins, protein disulfide isomerase, and calreticulin. Biochemistry 1999, 38 : 3369 3378.
63. Richard M, Biacabe AG, Streichenberger N, Ironside JW, Mohr M, Kopp N, Perret-Liaudet A. Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies. Acta Neuropathol (Berl) 2003, 105 : 296 302.
64. Ito H, Kamei K, Iwamoto I, Inaguma Y, García-Mata R, Sztul E, Kato K. Inhibition of proteasomes induces accumulation, phosphorylation, and recruitment of HSP27 and αB-crystallin to aggresomes. J Biochem 2002, 131 : 593 603.
65. Outeiro TF, Klucken J, Strathearn KE, Liu F, Nguyen P, Rochet JC, Hyman BT et al. Small heat shock proteins protect against α-synuclein-induced toxicity and aggregation. Biochem Biophys Res Commun 2006, 351 : 631 638.